TY - JOUR
T1 - Validation of the Visual/Verbal Analogue Scale of Food Ingesta (Ingesta-VVAS) in Oncology Patients Undergoing Chemotherapy
AU - Wijnhoven, Hanneke A.H.
AU - van der Velden, Loïs
AU - Broek, Carolina
AU - Broekhuizen, Marleen
AU - Bruynzeel, Patricia
AU - van Breen, Antoinette
AU - van Oostendorp, Nanda
AU - de Heer, Koen
N1 - Special Issue: Nutritional Status and Interventions for Patients with Cancer. Publisher Copyright: © 2022 by the authors.
PY - 2022/9/1
Y1 - 2022/9/1
N2 - This study aimed to: (1) externally validate the Visual/Verbal Analogue Scale of food ingesta (ingesta-VVAS) that previously showed good discrimination between oncology patients who ingest more or less energy than required; (2) explore the discriminative properties of other questions. Dietitians performed 322 interviews in 206 adult oncology patients undergoing chemotherapy in two Dutch hospitals, including a 24-h dietary recall, assessment of the ingesta-VVAS and 12 additional questions related to reduced food intake. The ingesta-VVAS score was linearly associated with energy intake as % of Total Energy Expenditure (TEE) (standardized beta = 0.39, p < 0.001), with no differences between groups based on use of oral nutritional supplements, body mass index, in/outpatient setting or sex. The accuracy of the ingesta-VVAS score to predict low energy intake (<75% of TEE) was poor (Area Under the Receiver Operating Characteristic curve (AUC) = 0.668, 95% CI 0.603–0.733). The optimal multivariate model included the ingesta-VVAS score and a question on ‘feeling sick’ (AUC = 0.680, 95% CI 0.615–0.746). In conclusion, in our study the ingesta-VVAS discriminates poorly between oncology patients undergoing chemotherapy who ingest more or less energy than required. Adding a question on feeling sick only slightly improved model performance. Further external validation is warranted.
AB - This study aimed to: (1) externally validate the Visual/Verbal Analogue Scale of food ingesta (ingesta-VVAS) that previously showed good discrimination between oncology patients who ingest more or less energy than required; (2) explore the discriminative properties of other questions. Dietitians performed 322 interviews in 206 adult oncology patients undergoing chemotherapy in two Dutch hospitals, including a 24-h dietary recall, assessment of the ingesta-VVAS and 12 additional questions related to reduced food intake. The ingesta-VVAS score was linearly associated with energy intake as % of Total Energy Expenditure (TEE) (standardized beta = 0.39, p < 0.001), with no differences between groups based on use of oral nutritional supplements, body mass index, in/outpatient setting or sex. The accuracy of the ingesta-VVAS score to predict low energy intake (<75% of TEE) was poor (Area Under the Receiver Operating Characteristic curve (AUC) = 0.668, 95% CI 0.603–0.733). The optimal multivariate model included the ingesta-VVAS score and a question on ‘feeling sick’ (AUC = 0.680, 95% CI 0.615–0.746). In conclusion, in our study the ingesta-VVAS discriminates poorly between oncology patients undergoing chemotherapy who ingest more or less energy than required. Adding a question on feeling sick only slightly improved model performance. Further external validation is warranted.
KW - accuracy
KW - cancer
KW - energy intake
KW - food intake
KW - nutrition
KW - screening
UR - http://www.scopus.com/inward/record.url?scp=85137545121&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85137545121&partnerID=8YFLogxK
U2 - https://doi.org/10.3390/nu14173515
DO - https://doi.org/10.3390/nu14173515
M3 - Article
C2 - 36079773
SN - 2072-6643
VL - 14
SP - 1
EP - 11
JO - NUTRIENTS
JF - NUTRIENTS
IS - 17
M1 - 3515
ER -